Medicament and Diagnosis for Spink1 Positive Cancer

Non-Confidential description of the invention

The invention is in the field of therapeutic medication for the treatment of cancer, preferably SPINK1 associated cancers. It also provides Biomarkers for Cancer and particularly detecting SPINK1-positive vs. SPINK1-negative subtype of cancers. The invention is also effective in SPINK1- positive cancer patients responding to the microRNA replacement therapy.

Inventors

Dr.Bushra Ateeq(BSBE), Mr.Vipul Bhatia(PhD Student,BSBE), Ms.Anjali Yadav(PhD Student,BSBE)

IPA

201611016564

Date of Filing

12/05/2016

Status

Date Of Grant

Downloads

Scroll to Top